Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

psoriasis-related juvenile idiopathic arthritis (JPsA) - Clinical Profile, Treatments & Trials | Kisho | Kisho

Rare Disease

psoriasis-related juvenile idiopathic arthritis

MONDO:0019436

Also known as:JPsAjuvenile psoriatic arthritispsoriasis-related JIA

Find Clinical TrialsTrials

Overview

Childhood arthritis typically associated with psoriasis.

Treatments1 FDA approved

Clinical Trials9 registered · 7 recruiting

Diagnosis

Biomarker and diagnostic research for psoriasis-related juvenile idiopathic arthritis has been reported in the published literature.

Treatment

Compiled from FDA-approved drug records, orphan drug designations, and FDA Adverse Event Reporting System (FAERS) safety data. GeneReviews management guidance is included where available.

1 FDA-approved treatment is available for psoriasis-related juvenile idiopathic arthritis, including ETANERCEPT (ENBREL, approved 1998).

Approved Therapies

Brand Name	Generic Name	Mechanism	Approved	Market Status

Prognosis

Estimated prevalence: Unknown (Unknown prevalence).

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

9 clinical trials registered, 7 recruiting. Interventions under study include drug therapy, other interventions, and biologic therapy. Pipeline includes 7 PHASE3, 1 PHASE1. Research is primarily industry-sponsored.

NCT ID	Title	Phase	Sponsor	Status
[NCT05767047](https://clinicaltrials.gov/study/NCT05767047)

Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 10:53 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:85436

GARD

Genetic and Rare Diseases Info Center

GARD:10970

Questions for Your Care Team

→What are the benefits and potential side effects of ENBREL for managing psoriasis-related juvenile idiopathic arthritis?
→Are any of the 9 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Disease patterns and progression	8	31%
Research summaries	7	27%
Clinical study results	6	23%
Laboratory research	3	12%
Testing and diagnosis research	1	4%
Patient case studies	1	4%

psoriasis-related juvenile idiopathic arthritis

Overview

Diagnosis

Treatment

Approved Therapies

Prognosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Clinical Trials

Recent Publications